The Boué–Dupuis formula and the exponential hypercontractivity in the Gaussian space
Electronic Communications in Probability · 01.01.2022 · 27 (none) · 1-13
DOI: 10.1214/22-ecp461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Electronic Communications in Probability, erschienen am 01.01.2022. Verfasst von Yuu Hariya und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
This paper concerns a variational representation formula for Wiener functionals. Let B={Bt}t≥0 be a standard d-dimensional Brownian motion. Boué and Dupuis (1998) showed that, for any bounded measurable functional F(B) of B up to time 1, the expectation EeF(B) admits a variational representation in terms of drifted Brownian motions. In this paper, with a slight modification of insightful reasoning by Lehec (2013) allowing also F(B) to be a functional of B over the whole time interval, we prove that the Boué–Dupuis formula holds true provided that both eF(B) and F(B) are integrable, relaxing conditions in earlier works. We also show that the formula implies the exponential hypercontractivity of the Ornstein–Uhlenbeck semigroup in Rd, and hence, due to their equivalence, implies the logarithmic Sobolev inequality in the d-dimensional Gaussian space.
Zitieren
APA
Hariya, Y., & Watanabe, S. (2022). The Boué–Dupuis formula and the exponential hypercontractivity in the Gaussian space. Electronic Communications in Probability, 27(none), 1-13. https://doi.org/10.1214/22-ecp461
Vancouver
Hariya Y, Watanabe S. The Boué–Dupuis formula and the exponential hypercontractivity in the Gaussian space. Electronic Communications in Probability. 2022;27(none):1-13. doi:10.1214/22-ecp461
BibTeX
@article{Hariya2022,
author = {Hariya, Yuu and Watanabe, Sou},
title = {The Boué–Dupuis formula and the exponential hypercontractivity in the Gaussian space},
journal = {Electronic Communications in Probability},
year = {2022},
volume = {27},
number = {none},
pages = {1--13},
doi = {10.1214/22-ecp461}
}
EUVIMED